StockData
McKesson Corp logo

McKesson Corp (MCK) stock

MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3027% above fair value
$1084.43−7.24 (-0.66%)

Close on Nov 18, 2026Market cap $126.43BP/E 29.0Yield 0.29%

McKesson net income

Net income is the profit left for shareholders after every expense, interest and tax.

McKesson's net income for the twelve months ending Jun 30, 2026 was $4.59B, up 45.1% year over year. For fiscal 2026 it was $4.76B, up 44.5% from the year before. Over ten years it grew 7.7% a year on average. The highest annual figure on record is $5.07B in fiscal 2017.

Annual net income

PeriodPeriod endValueChange
FY2026Mar 31, 2026$4.76B+44.5%
FY2025Mar 31, 2025$3.30B+9.8%
FY2024Mar 31, 2024$3.00B-15.7%
FY2023Mar 31, 2023$3.56B+219.6%
FY2022Mar 31, 2022$1.11B–
FY2021Mar 31, 2021-$4.54B-604.3%
FY2020Mar 31, 2020$900.00M+2547.1%
FY2019Mar 31, 2019$34.00M-49.3%
FY2018Mar 31, 2018$67.00M-98.7%
FY2017Mar 31, 2017$5.07B+124.5%
FY2016Mar 31, 2016$2.26B+53.0%
FY2015Mar 31, 2015$1.48B+16.9%
FY2014Mar 31, 2014$1.26B-5.6%
FY2013Mar 31, 2013$1.34B-4.6%
FY2012Mar 31, 2012$1.40B+16.7%
FY2011Mar 31, 2011$1.20B-4.8%
FY2010Mar 31, 2010$1.26B+53.5%
FY2009Mar 31, 2009$823.00M–

Quarterly net income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$614.00M-21.7%
Q4 FY2026CQ1 2026Mar 31, 2026$1.68B+33.5%
Q3 FY2026CQ4 2025Dec 31, 2025$1.19B+34.9%
Q2 FY2026CQ3 2025Sep 30, 2025$1.11B+360.6%
Q1 FY2026CQ2 2025Jun 30, 2025$784.00M-14.3%
Q4 FY2025CQ1 2025Mar 31, 2025$1.26B+59.3%
Q3 FY2025CQ4 2024Dec 31, 2024$879.00M+49.2%
Q2 FY2025CQ3 2024Sep 30, 2024$241.00M-63.7%
Q1 FY2025CQ2 2024Jun 30, 2024$915.00M-4.5%
Q4 FY2024CQ1 2024Mar 31, 2024$791.00M+0.5%
Q3 FY2024CQ4 2023Dec 31, 2023$589.00M-45.4%
Q2 FY2024CQ3 2023Sep 30, 2023$664.00M-28.3%
Q1 FY2024CQ2 2023Jun 30, 2023$958.00M+24.7%
Q4 FY2023CQ1 2023Mar 31, 2023$787.00M+113.9%
Q3 FY2023CQ4 2022Dec 31, 2022$1.08B–
Q2 FY2023CQ3 2022Sep 30, 2022$926.00M+246.8%
Q1 FY2023CQ2 2022Jun 30, 2022$768.00M+58.0%
Q4 FY2022CQ1 2022Mar 31, 2022$368.00M-44.7%
Q3 FY2022CQ4 2021Dec 31, 2021-$7.00M–
Q2 FY2022CQ3 2021Sep 30, 2021$267.00M-53.7%
Q1 FY2022CQ2 2021Jun 30, 2021$486.00M+9.5%
Q4 FY2021CQ1 2021Mar 31, 2021$666.00M-34.8%
Q3 FY2021CQ4 2020Dec 31, 2020-$6.23B-3447.3%
Q2 FY2021CQ3 2020Sep 30, 2020$577.00M–
Q1 FY2021CQ2 2020Jun 30, 2020$444.00M+5.0%
Q4 FY2020CQ1 2020Mar 31, 2020$1.02B–
Q3 FY2020CQ4 2019Dec 31, 2019$186.00M-60.3%
Q2 FY2020CQ3 2019Sep 30, 2019-$730.00M-246.3%
Q1 FY2020CQ2 2019Jun 30, 2019$423.00M–
Q4 FY2019CQ1 2019Mar 31, 2019-$796.00M–
Q3 FY2019CQ4 2018Dec 31, 2018$469.00M-48.1%
Q2 FY2019CQ3 2018Sep 30, 2018$499.00M+49800.0%
Q1 FY2019CQ2 2018Jun 30, 2018-$138.00M-144.7%
Q4 FY2018CQ1 2018Mar 31, 2018-$1.15B-131.9%
Q3 FY2018CQ4 2017Dec 31, 2017$903.00M+42.7%
Q2 FY2018CQ3 2017Sep 30, 2017$1.00M-99.7%
Q1 FY2018CQ2 2017Jun 30, 2017$309.00M–
Q4 FY2017CQ1 2017Mar 31, 2017$3.59B–
Q3 FY2017CQ4 2016Dec 31, 2016$633.00M–
Q2 FY2017CQ3 2016Sep 30, 2016$307.00M–

More McKesson figures

See a number that looks wrong?